MedPath

MiMedx

MiMedx logo
🇺🇸United States
Ownership
Public
Established
2008-02-28
Employees
895
Market Cap
-
Website
http://www.mimedx.com
Introduction

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Use of Human Dehydrated Umbilical Cord Allograft in Supraspinatus Tendon Repair

Not Applicable
Completed
Conditions
Shoulder Sprain
Supraspinatus Tear
Shoulder Injury
Interventions
Other: Placebo
Other: Human dehydrated umbilical cord allograft
First Posted Date
2017-03-20
Last Posted Date
2019-12-18
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
25
Registration Number
NCT03084068
Locations
🇺🇸

Hand & UpperEx Center, Wexford, Pennsylvania, United States

Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
Interventions
Other: Saline Placebo
Other: Amniotic Fluid
First Posted Date
2017-03-08
Last Posted Date
2020-11-13
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
156
Registration Number
NCT03074526
Locations
🇺🇸

Central Research Associates, Inc, Birmingham, Alabama, United States

🇺🇸

Southeastern Center for Clinical Trials, Atlanta, Georgia, United States

🇺🇸

Weil Foot, Ankle and Orthopedic Institute, Des Plaines, Illinois, United States

and more 1 locations

Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers

Not Applicable
Completed
Conditions
Pressure Ulcer
Interventions
Other: dHACM
First Posted Date
2016-08-10
Last Posted Date
2018-08-24
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
10
Registration Number
NCT02861560
Locations
🇺🇸

Shepherd Spine Center, Atlanta, Georgia, United States

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Diabetic Foot Ulcers
Interventions
Biological: EpiCord
Other: Standard of Care
First Posted Date
2016-07-26
Last Posted Date
2022-05-13
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
130
Registration Number
NCT02844660
Locations
🇺🇸

Costal Podiatry, Virginia Beach, Virginia, United States

🇺🇸

ILD Research, Carlsbad, California, United States

🇺🇸

Ambulatory Foot & Ankle Center, PC, Hampton, Virginia, United States

and more 10 locations

Evaluation of Amniotic Fluid Product in Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Other: Placebo Control
Other: Amniotic Fluid 4.0ml dose
Other: Amniotic Fluid 2.0ml dose
First Posted Date
2016-05-11
Last Posted Date
2017-10-26
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
60
Registration Number
NCT02768155
Locations
🇺🇸

Weil Foot, Ankle and Orthopedic Institute, Des Plaines, Illinois, United States

🇺🇸

Central Research Associates, Inc, Birmingham, Alabama, United States

Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.

Not Applicable
Terminated
Conditions
Treatment of Partial Thickness Burns
Interventions
Other: Dehydrated Human Amnion/Chorion Membrane
Device: Mepilex Ag
First Posted Date
2016-05-09
Last Posted Date
2022-05-17
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
23
Registration Number
NCT02765737
Locations
🇺🇸

Bruce Cairns Surgery Burn Center, Chapel Hill, North Carolina, United States

🇺🇸

Arizona Burn Center, Phoenix, Arizona, United States

🇺🇸

University of San Diego Nedical Center, San Diego, California, United States

and more 3 locations

dHACM Mesh In the Treatment of Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Diabetic Foot Ulcers
Interventions
Other: EpiFix Mesh
First Posted Date
2015-10-28
Last Posted Date
2017-08-25
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
10
Registration Number
NCT02589210
Locations
🇺🇸

Professional Education and Research Institute, Roanoke, Virginia, United States

dHACM In the Treatment of Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Diabetic Foot Ulcers
Interventions
Other: EpiFix
First Posted Date
2015-10-27
Last Posted Date
2017-08-25
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
16
Registration Number
NCT02587104
Locations
🇨🇦

The Mayer Institute, Hamilton, Ontario, Canada

DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)

Not Applicable
Completed
Conditions
Erectile Dysfunction
Interventions
Procedure: RALP using full nerve sparing technique
Other: dHACM Application
First Posted Date
2015-08-18
Last Posted Date
2018-09-28
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
230
Registration Number
NCT02526173
Locations
🇺🇸

Florida Hospital: Global Robotics Institute, Celebration, Florida, United States

Micronized dHACM Injectable for the Treatment of Plantar Fasciitis

Phase 2
Completed
Conditions
Fasciitis, Plantar
Interventions
Other: AmnioFix® Injectable
Drug: Saline Injection
First Posted Date
2015-04-27
Last Posted Date
2020-11-17
Lead Sponsor
MiMedx Group, Inc.
Target Recruit Count
147
Registration Number
NCT02427191
Locations
🇺🇸

Southern Arizona VA Health Care System, Tucson, Arizona, United States

🇺🇸

James A. Lovell Federal Health Care Center, North Chicago, Illinois, United States

🇺🇸

Scott & White Healthcare, Temple, Texas, United States

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath